PT  - JOURNAL ARTICLE
AU  - Lasser, Jana
AU  - Hell, Timotheus
AU  - Garcia, David
TI  - High COVID-19 vaccine coverage allows for a re-opening of European universities
AID  - 10.1101/2021.11.16.21266383
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.11.16.21266383
4099  - http://medrxiv.org/content/early/2021/11/16/2021.11.16.21266383.short
4100  - http://medrxiv.org/content/early/2021/11/16/2021.11.16.21266383.full
AB  - Returning universities to full on-campus operations while the COVID-19 pandemic is ongoing has been a controversial discussion in many countries. The risk of large outbreaks in dense course settings is contrasted by the benefits of in-person teaching. Transmission risk depends on a range of parameters, such as vaccination coverage, number of contacts and adoption of non-pharmaceutical intervention measures (NPIs). Due to the generalised academic freedom in Europe, many universities are asked to autonomously decide on and implement intervention measures and regulate on-campus operations. In the context of rapidly changing vaccination coverage and parameters of the virus, universities often lack the scientific facts to base these decisions on. To address this problem, we analyse a calibrated, data-driven simulation of transmission dynamics of 10755 students and 974 faculty in a medium-sized university. We use a co-location network reconstructed from student enrolment data and calibrate transmission risk based on outbreak size distributions in other Austrian education institutions. We focus on actionable interventions that are part of the already existing decision-making process of universities to provide guidance for concrete policy decisions. Here we show that with the vaccination coverage of about 80% recently reported for students in Austria, universities can be safely reopened if they either mandate masks or reduce lecture hall occupancy to 50%. Our results indicate that relaxing NPIs within an organisation based on the vaccination coverage of its sub-population can be a way towards limited normalcy, even if nation wide vaccination coverage is not sufficient to prevent large outbreaks yet.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://doi.org/10.17605/OSF.IO/UPX7R https://doi.org/10.17605/OSF.IO/UPX7R